aTyr Pharma announces stock offering of up to $79.99 million
ATYR•aTyr Pharma may sell up to $79.99 million of common stock from time to time through Jefferies under an existing open-market sale agreement.
1. Stock sale agreement
aTyr Pharma may offer and sell up to $79.99 million of common stock through Jefferies under an open-market sale agreement dated April 22, 2022, and amended December 23, 2024.




